Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial.
暂无分享，去创建一个
C. Criscitiello | S. Cosimo | E. Azambuja | D. Agbor-tarh | José Baselga | Martine Piccart | Holger Eidtmann | Hatem A. Azim | Ian Bradbury | Isabel T. Rubio | J. Baselga | M. Piccart | H. A. Azim | H. Eidtmann | I. Bradbury | I. T. Rubio